Ulrike Flierl

Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators

Ulrike Flierl, Tracy L. Nero, Bock Lim et al. · The Journal of Experimental Medicine · 2015 · 109 citations · Full text

Medicine, Molecular Biology, Pharmacology +17

Early Escalation of Mechanical Circulatory Support Stabilizes and Potentially Rescues Patients in Refractory Cardiogenic Shock

Jörn Tongers, Jan‐Thorben Sieweke, C. Kühn et al. · Circulation Heart Failure · 2020 · 92 citations

Medicine, Cardiology, Cardiothoracic Surgery +13

Improvement of vascular function by acute and chronic treatment with the PDE‐5 inhibitor sildenafil in experimental diabetes mellitus

Andreas Schäfer, Daniela Fraccarollo, Stephanie Pförtsch et al. · British Journal of Pharmacology · 2007 · 74 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Renal Denervation Reduces Monocyte Activation and Monocyte–Platelet Aggregate Formation

Maria T. K. Zaldivia, Jennifer Rivera, Dagmara Hering et al. · Hypertension · 2016 · 73 citations · Full text

Medicine, Cardiology, Physiology +15

The new INNOVANCE® PFA P2Y cartridge is sensitive to the detection of the P2Y₁₂receptor inhibition

Juergen Koessler, Anna L. Kobsar, Mirjana S. Rajkovic et al. · Platelets · 2010 · 49 citations

Medicine, Pharmaceutics, Pharmacology +16